Encorafenib Market Gains Momentum as Targeted Cancer Therapies Drive Global Demand

https://growthmarketreports.co....m/report/encorafenib

The global Encorafenib market reached USD 1.22 billion in 2025, driven by rising melanoma and colorectal cancer incidence worldwide.Encorafenib Market is witnessing steady attention as precision oncology continues to reshape cancer treatment worldwide. Growing adoption of targeted therapies, increasing awareness of personalized medicine, and ongoing advancements in oncology research are supporting the market’s long-term outlook.